- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Internal Medicine
Studies Detail Thrombosis Risks Associated with Different COVID-19 Vaccines
June 27, 2022
Dr. Gregory Weiss provides perspective on a recent study detailing the risks of thrombosis observed with different COVID-19 vaccines among patients from a group of countries in Europe.
USPSTF Issues Cautious Recommendations on Nutritional Supplement Use for Preventing Cardiovascular Disease
June 21, 2022
On June 21, the USPSTF released a new recommendation statement related to use of vitamin, mineral, or multivitamin supplements for the prevention of cancer and cardiovascular disease in adult patients, which replace the organization's 2014 recommendations on the subject.
Prediabetes Not as Benign as Once Believed, Associated with Increased Risk of Heart Attacks
June 17, 2022
An analysis of the National Inpatient Sample details the statistically significant increases in the risk of experiencing myocardial infarction, PCI, or CABG in patients with prediabetes compared to their normoglycemic counterparts.
Cardiovascular Risks in Childhood Cancer Survivors Often Overlooked, Undertreated
June 14, 2022
Using data from a large study of childhood cancer survivors and NHANES, investigators provide insight into the undertreatment and underdiagnosis of cardiovascular risk factors among survivors of childhood cancer compared to the general US population.
Forgoing Vaccination Could Increase Mortality Risk in Heart Failure Patients
June 13, 2022
A retrospective cohort study of patients from the Mount Sinai Health System EHR suggests patients with heart failure who received a COVID-19 vaccination saw their risk of mortality decreased by more than 60% compared to unvaccinated individuals.
Finding "Sweet Spot" for Omega-3 Fatty Acid Consumption Could Help Lower Blood Pressure
June 01, 2022
A systematic review and meta-analysis of more than 70 RCTs details a J-shape dose-response relationship between omega-3 fatty acid consumption and blood pressure, with 2-3 grams per day considered the optimal dose for blood pressure lowering.
No Red Flags for Fracture Risk with SGLT2 Inhibitors in Diabetic Kidney Disease
May 31, 2022
An analysis of data from more than 75,000 patients with diabetic kidney disease details the risk of fracture among new users of SGLT2 inhibitors compared to new users of DPP-4 inhibitors.
Too Much or Too Little of a Good Thing: Thyroid Treatment and Cardiovascular Risk
May 30, 2022
Dr. Gregory Weiss breaks down a recent JAMA study that provides estimates of the impact over- and under-treatment with thyroid hormone treatment on cardiovascular disease risk in a cohort of US Veterans.
Uncontrolled Blood Pressure, HbA1c Common Among Hospitalized Heart Failure Patients
May 09, 2022
An analysis of NHANES surveys from 2001-2018 describes the overall prevalence of uncontrolled hypertension and HbA1c in adults with heart failure and provides insight into racial/ethnic disparities in prevalence.
Study Details in Trends of Cardiovascular Death Among Cancer Patients in US Since 1999
May 06, 2022
Investigators use data from the CDC WONDER database to assess contemporary trends in disease-specific cardiovascular causes of mortality among cancer patients in the US from 1999 to 2019.